Autologous tumoral esterase-driven therapeutic polymers sequentially orchestrated antigen-induction, STING activation and anti-angiogenesis for systemic cancer immune therapy

Authors: Qiu, Nasha ^{a, 1, ⁎}, Xu, Chang ^{b, 1}, Zhang, Zhen ^{c, 1}, Wang, Rui ^{b, 1}, Wei, Xuyong ^{a, 1}, Xie, Yangla ^a, Wang, Shuai ^a, Lu, Di ^d, Wang, Kai ^d, Xu, Shengjun ^a, Shen, Chenchen ^a, Su, Renyi ^b, Cen, Beini ^a, Liu, Yanpeng ^a, Shen, Youqing ^{c, ⁎⁎}, Xu, Xiao ^{d, e, ⁎⁎⁎}

Source: In Biomaterials September 2025 320

Dendritic cell subsets and implications for cancer immunotherapy

Authors: Michael Y. Chen, Felicia Zhang, Simon Peter Goedegebuure, William E. Gillanders

Source: Frontiers in Immunology, Vol 15 (2024)

Subject Terms: dendritic cell (DC), dendritic cell vaccine, dendritic cell subtypes, cancer immune therapy, cancer vaccination, tumor neoantigen, Immunologic diseases. Allergy, RC581-607

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fimmu.2024.1393451/full; https://doaj.org/toc/1664-3224

Access URL: https://doaj.org/article/4b57a07e1bda42679b4295753dcebc0a

A novel dual mechanism-of-action bispecific PD-1-IL-2v armed by a 'βγ-only' interleukin-2 variant

Authors: Yongji Jiang, Chuyuan Chen, Yuan Liu, Rong Wang, Chuan Feng, Lili Cai, Shuang Chang, Lei Zhao

Source: Frontiers in Immunology, Vol 15 (2024)

Subject Terms: interleukin-2, cytokine, bispecific antibody, T cell activation, cancer immune therapy, IL-2 variant, Immunologic diseases. Allergy, RC581-607

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fimmu.2024.1369376/full; https://doaj.org/toc/1664-3224

Access URL: https://doaj.org/article/2786776c7a4448c086ec2c2d8aa3a66e

A multicenter retrospective analysis: Factors influencing hepatic adverse events induced by immunotherapy in advanced liver cancer

Authors: Rui Zou, Yunhe Hao, Yiyao Wang, Feihu Yan, Xu Peng, Zepeng Huang, Gang Chen

Source: Cancer Reports, Vol 7, Iss 2, Pp n/a-n/a (2024)

Subject Terms: immune checkpoint inhibitor, immune‐related adverse events, liver cancer immune therapy, liver toxicity, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/2573-8348

Access URL: https://doaj.org/article/7dad1a816e0642b48fcc09ae81d44891

Oncolytic Virus Immunotherapy

Contributors: Marchini, Antonio, Ilkow, Carolina S., Melcher, Alan

Subject Terms: oncolytic viruses, melanoma, immunotherapy, checkpoint inhibitors, combinatory therapy, reovirus, oncolytic virus, adenovirus, oncolytic, virotherapy, targeting, immunogenic cell death, αvβ6 integrin, oncolytic adenovirus, cancer immunotherapy, multi-stage, immunostimulatory, arming, HSV-1, clinical trials, newcastle disease virus, NDV, cancer, immune checkpoint inhibitor, PD-1, PD-L1, CTLA-4, type I interferon, herpes simplex virus, retargeted virus, tropism retargeting, tumor, checkpoint inhibitor, vaccination, antigen-agnostic vaccination, HER2, parvovirus, tumor microenvironment, combination therapy, glioblastoma, pancreatic cancer, colorectal cancer, measles virus, vector engineering, immune checkpoint blockade, antitumor immune response, delivery, genetic modification, biomarkers, personalized oncolyticvirotherapy, class I HLA, immunosurveillance, immunoediting, oncogenic signaling, RAS, DNA methyltransferase inhibitor (DNMTi), viral mimicry, epigenetic silencing, adoptive T cell therapy, CAR T cell, pancreatic ductal adenocarcinoma, vesicular stomatitis virus, small molecule, cancer immune therapy, cancer therapy, Medicine and Nursing, Clinical and internal medicine

File Description: image/jpeg

Access URL: https://directory.doabooks.org/handle/20.500.12854/81172
https://mdpi.com/books/pdfview/book/5203

Strategies to overcome myeloid cell induced immune suppression in the tumor microenvironment

Authors: Jennifer Cao, Lyndah Chow, Steven Dow

Source: Frontiers in Oncology, Vol 13 (2023)

Subject Terms: cancer, immune suppresion, tumor associate macrophages (TAM), myeloid derived suppressor cells (MDSC), tumor associated neutrophils (TAN), cancer immune therapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2023.1116016/full; https://doaj.org/toc/2234-943X

Access URL: https://doaj.org/article/c3d6ad7d58c345bfba0044a443110eb9

An arginase1- and PD-L1-derived peptide-based vaccine for myeloproliferative neoplasms: A first-in-man clinical trial

Authors: Jacob Handlos Grauslund, Morten Orebo Holmström, Evelina Martinenaite, Thomas Landkildehus Lisle, Hannah Jorinde Glöckner, Daniel El Fassi, Uffe Klausen, Rasmus E. J. Mortensen, Nicolai Jørgensen, Lasse Kjær, Vibe Skov, Inge Marie Svane, Hans Carl Hasselbalch, Mads Hald Andersen

Source: Frontiers in Immunology, Vol 14 (2023)

Subject Terms: myeloproliferative neoplasms, cancer immune therapy, arginase-1, PD-L1, immune modulatory vaccines, Immunologic diseases. Allergy, RC581-607

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fimmu.2023.1117466/full; https://doaj.org/toc/1664-3224

Access URL: https://doaj.org/article/5bb1896ca9234691adc0750d751600e6

Potentiating Cancer Immune Therapy via Nanomaterials and Purinergic Signaling

Authors: Davide Ferrari, Stefania Gessi, Stefania Merighi, Manuela Nigro, Alessia Travagli, Jorge S. Burns

Source: Frontiers in Cell and Developmental Biology, Vol 10 (2022)

Subject Terms: cancer immune therapy, nanomaterials, tumor microenvironment (TME), A2A adenosine receptor, P2X7 (purino) receptor, Biology (General), QH301-705.5

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fcell.2022.893709/full; https://doaj.org/toc/2296-634X

Access URL: https://doaj.org/article/a8af3b9e904d4b0cab1699523fbd8d34

NKG2A expression identifies a subset of human Vδ2 T cells exerting the highest antitumor effector functions

Authors: Valentina Cazzetta, Elena Bruni, Sara Terzoli, Claudia Carenza, Sara Franzese, Rocco Piazza, Paolo Marzano, Matteo Donadon, Guido Torzilli, Matteo Cimino, Matteo Simonelli, Lorenzo Bello, Anna Villa, Likai Tan, Sarina Ravens, Immo Prinz, Domenico Supino, Federico S. Colombo, Enrico Lugli, Emanuela Marcenaro, Eric Vivier, Silvia Della Bella, Joanna Mikulak, Domenico Mavilio

Source: Cell Reports, Vol 37, Iss 3, Pp 109871- (2021)

Subject Terms: Vδ2 T cells, NKG2A immune checkpoint, hyper-reactivity, immune education, cancer, cancer immune-therapy, Biology (General), QH301-705.5

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2211124721013383; https://doaj.org/toc/2211-1247

Access URL: https://doaj.org/article/05645d72a7ba409498bd2a6ec58b97fb

Reprogramming Immune Cells for Enhanced Cancer Immunotherapy: Targets and Strategies

Authors: Yan Dong, Zhuo Wan, Xiaotong Gao, Guodong Yang, Li Liu

Source: Frontiers in Immunology, Vol 12 (2021)

Subject Terms: cancer immune therapy, cell engineering, targets, strategies, immune cells, Immunologic diseases. Allergy, RC581-607

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fimmu.2021.609762/full; https://doaj.org/toc/1664-3224

Access URL: https://doaj.org/article/1d88203204a5473fa76c648e8bfb0e71

Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With CALR-Mutant Chronic Myeloproliferative Neoplasms

Authors: Jacob Handlos Grauslund, Morten Orebo Holmström, Nicolai Grønne Jørgensen, Uffe Klausen, Stine Emilie Weis-Banke, Daniel El Fassi, Claudia Schöllkopf, Mette Borg Clausen, Lise Mette Rahbek Gjerdrum, Marie Fredslund Breinholt, Julie Westerlin Kjeldsen, Morten Hansen, Steffen Koschmieder, Nicolas Chatain, Guy Wayne Novotny, Jesper Petersen, Lasse Kjær, Vibe Skov, Özcan Met, Inge Marie Svane, Hans Carl Hasselbalch, Mads Hald Andersen

Source: Frontiers in Oncology, Vol 11 (2021)

Subject Terms: myeloproliferative neoplasms, cancer immune therapy, cancer vaccines, neo-antigen, calreticulin, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2021.637420/full; https://doaj.org/toc/2234-943X

Access URL: https://doaj.org/article/348bdbd7063d4ceeaa8716a415e505fe

The Emerging Role of the Mammalian Glycocalyx in Functional Membrane Organization and Immune System Regulation

Authors: Leonhard Möckl

Source: Frontiers in Cell and Developmental Biology, Vol 8 (2020)

Subject Terms: glycocalyx, membrane organization, cancer, immune system, cancer immune therapy, immunosynapse, Biology (General), QH301-705.5

File Description: electronic resource

Relation: https://www.frontiersin.org/article/10.3389/fcell.2020.00253/full; https://doaj.org/toc/2296-634X

Access URL: https://doaj.org/article/302363c3e1b0420d8b7ac429291a059f

Targeting CD147 for T to NK Lineage Reprogramming and Tumor Therapy

Authors: Jie-Jie Geng, Juan Tang, Xiang-min Yang, Ruo Chen, Yang Zhang, Kui Zhang, Jin-Lin Miao, Zhi-Nan Chen, Ping Zhu

Source: EBioMedicine, Vol 20, Iss C, Pp 98-108 (2017)

Subject Terms: BCL11b, Cancer immune-therapy, CD147, Trans-differentiation, Thymocyte development, Medicine, Medicine (General), R5-920

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2352396417302207; https://doaj.org/toc/2352-3964

Access URL: https://doaj.org/article/8c427bdca82243e8b4d390057b95f907

Precision glycocalyx editing as a strategy for cancer immunotherapy

Authors: Xiao, Han, Woods, Elliot C., Vukojicic, Petar, Bertozzi, Carolyn R.

Source: Proceedings of the National Academy of Sciences of the United States of America, 2016 Sep . 113(37), 10304-10309.

Access URL: https://www.jstor.org/stable/26471773

This result is not displayed to guests.
Login for full access.

Cancer Immune Therapy: Current and Future Strategies.

Authors: Borden, Ernest C., Maciejewski, Jaroslaw

Source: New England Journal of Medicine. 11/20/2003, Vol. 349 Issue 21, p2082-2082. 1p.

Subject Terms: *CANCER treatment, *NONFICTION

Reviews & Products: CANCER Immune Therapy: Current & Future Strategies (Book)

People: STUHLER, Gernot, WALDEN, Peter

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.